Comparative Oncology Today

Khanna, 2006, The dog as a cancer model, Nat Biotechnol, 24, 1065, 10.1038/nbt0906-1065b

Vail, 2000, Spontaneously occurring tumors of companion animals as models for human cancer, Cancer Invest, 18, 781, 10.3109/07357900009012210

Hansen, 2004, Spontaneous and genetically engineered animal models; use in preclinical cancer drug development, Eur J Cancer, 40, 858, 10.1016/j.ejca.2003.11.031

Withrow, 2007

Antinoff, 2004, Ferret oncology: diseases, diagnostics, and therapeutics, Vet Clin North Am Exot Anim Pract, 7, 579, 10.1016/j.cvex.2004.05.001

Olson, 2007, Using the canine genome to cure cancer and other diseases, Theriogenology, 68, 378, 10.1016/j.theriogenology.2007.04.016

Naylor, 1996, Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models, Oncology, 53, 8, 10.1159/000227634

Bukowski, 1998, Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk, J Toxicol Environ Health A, 54, 579, 10.1080/009841098158719

Hahn, 1994, Naturally occurring tumors in dogs as comparative models for cancer therapy research, In Vivo, 8, 133

Mutsaers, 2003, Canine transitional cell carcinoma, J Vet Intern Med, 17, 136, 10.1111/j.1939-1676.2003.tb02424.x

Rusk, 2006, Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers, Clin Cancer Res, 12, 7444, 10.1158/1078-0432.CCR-06-0109

Rusk, 2006, Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma, Clin Cancer Res, 12, 7456, 10.1158/1078-0432.CCR-06-0110

Thamm, 2005, Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation, Clin Cancer Res, 11, 4827, 10.1158/1078-0432.CCR-04-2510

Buchholz, 2005, Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma, Clin Cancer Res, 11, 7538, 10.1158/1078-0432.CCR-05-0490

Vail, 2004, Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies, Semin Oncol, 31, 16, 10.1053/j.seminoncol.2004.08.002

London, 2003, Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies, Clin Cancer Res, 9, 2755

Khanna, 2003, Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers, Curr Cancer Drug Targets, 3, 265, 10.2174/1568009033481903

Khanna, 2002, A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy, Clin Cancer Res, 8, 2406

MacEwen, 1999, Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor, Clin Cancer Res, 5, 4249

Hershey, 1999, Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model, Clin Cancer Res, 5, 2653

Khanna, 1997, Nebulized interleukin 2 liposomes: aerosol characteristics and biodistribution, J Pharm Pharmacol, 49, 960, 10.1111/j.2042-7158.1997.tb06024.x

Vail, 1995, Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial, Clin Cancer Res, 1, 1165

Kurzman, 1995, Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin, Clin Cancer Res, 1, 1595

Kurzman, 1994, Effect of liposome-muramyl tripeptide combined with recombinant canine granulocyte colony-stimulating factor on canine monocyte activity, Cancer Biother, 9, 113, 10.1089/cbr.1994.9.113

Withrow, 1993, Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma, Cancer, 71, 2484, 10.1002/1097-0142(19930415)71:8<2484::AID-CNCR2820710810>3.0.CO;2-D

LaRue, 1989, Limb-sparing treatment for osteosarcoma in dogs, J Am Vet Med Assoc, 195, 1734

Elmslie, 1997, Genetic immunotherapy for cancer, Semin Vet Med Surg (Small Anim), 12, 193, 10.1016/S1096-2867(97)80033-3

Dow, 1997, Expression of bacterial superantigen genes in mice induces localized mononuclear cell inflammatory responses, J Clin Invest, 99, 2616, 10.1172/JCI119450

Sutter, 2007, A single IGF1 allele is a major determinant of small size in dogs, Science, 316, 112, 10.1126/science.1137045

Patrick, 2006, Classification of canine urinary bladder urothelial tumours based on the World Health Organization/International Society of Urological Pathology consensus classification, J Comp Pathol, 135, 190, 10.1016/j.jcpa.2006.07.002

Ostrander, 2006

Thomas, 2005, Construction of a 2-Mb resolution BAC microarray for CGH analysis of canine tumors, Genome Res, 15, 1831, 10.1101/gr.3825705

Lindblad-Toh, 2005, Genome sequence, comparative analysis and haplotype structure of the domestic dog, Nature, 438, 803, 10.1038/nature04338

Lee, 2004, Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors, J Vet Sci, 5, 63, 10.1292/jvms.66.63

Jones, 2004, Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis, J Vet Diagn Invest, 16, 95, 10.1177/104063870401600201

Thomas, 2003, Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes, Br J Cancer, 89, 1530, 10.1038/sj.bjc.6601275

Pryer, 2003, Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors, Clin Cancer Res, 9, 5729

Lingaas, 2003, A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog, Hum Mol Genet, 12, 3043, 10.1093/hmg/ddg336

Ozaki, 2002, Mast cell tumors of the gastrointestinal tract in 39 dogs, Vet Pathol, 39, 557, 10.1354/vp.39-5-557

Lee, 2002, Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors, J Vet Sci, 3, 321, 10.4142/jvs.2002.3.4.321

Wakui, 2001, Prognostic status of p53 gene mutation in canine mammary carcinoma, Anticancer Res, 21, 611

Setoguchi, 2001, Aberrations of the p53 tumor suppressor gene in various tumors in dogs, Am J Vet Res, 62, 433, 10.2460/ajvr.2001.62.433

Reguera, 2000, Canine mast cell tumors express stem cell factor receptor, Am J Dermatopathol, 22, 49, 10.1097/00000372-200002000-00010

London, 1999, Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit, Exp Hematol, 27, 689, 10.1016/S0301-472X(98)00075-7

Van Leeuwen, 1996, P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog, Anticancer Res, 16, 3737

London, 1996, Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours, J Comp Pathol, 115, 399, 10.1016/S0021-9975(96)80074-0

Hayes, 1977, Epidemiological features of canine renal neoplasms, Cancer Res, 37, 2553

Modiano, 2005, Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk, Cancer Res, 65, 5654, 10.1158/0008-5472.CAN-04-4613

Kiupel, 2004, The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors, Vet Pathol, 41, 371, 10.1354/vp.41-4-371

Olson, 2007, Fighting cancer in dogs, J Am Vet Med Assoc, 230, 1280

Porrello, 2006, Oncology of companion animals as a model for humans. An overview of tumor histotypes, J Exp Clin Cancer Res, 25, 97

Lana, 2006, Diagnosis of mediastinal masses in dogs by flow cytometry, J Vet Intern Med, 20, 1161, 10.1111/j.1939-1676.2006.tb00716.x

Lana, 2006, Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma, J Vet Intern Med, 20, 329, 10.1111/j.1939-1676.2006.tb02864.x

Proschowsky, 2003, Mortality of purebred and mixed-breed dogs in Denmark, Prev Vet Med, 58, 63, 10.1016/S0167-5877(03)00010-2

MacEwen, 1994, Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review, J Drug Target, 2, 391, 10.3109/10611869408996814

Kamb, 2007, Why is cancer drug discovery so difficult?, Nat Rev Drug Discov, 6, 115, 10.1038/nrd2155

Kola, 2004, Can the pharmaceutical industry reduce attrition rates?, Nat Rev Drug Discov, 3, 711, 10.1038/nrd1470

Available at: www.acvim.org.

Available at: www.acvr.org.

Available at: www.vetcancersociety.org.

Available at: ccr.cancer.gov/resources/cop/scientists/resource_genomics.asp.

Available at: ccr.cancer.gov/resources/cop.